Nutrition Facts overhaul is a missed opportunity for long chain omega-3s EPA and DHA, says GOED

GOED 'respectfully disagrees' with the FDA over its assessment of the evidence supporting the benefits of EPA and DHA

The FDA’s overhaul of the Nutrition Facts panel misses a public health opportunity by prohibiting firms from evening highlighting long chain omega-3 fatty acids EPA and DHA on the panel on a voluntary basis, says GOED, the Global Organization for EPA and DHA Omega‐3s.

While the FDA notes that a review it conducted in 2004 found there was “supportive, but not conclusive, research” to suggest EPA and DHA may reduce the risk of coronary heart disease, it says listing them on the Nutrition Facts panel is not very useful because there are no established dietary reference intakes (DRIs) for EPA and DHA, while their role in reducing chronic disease risk is not “well-established”.

Growing body of evidence supports the cardiovascular benefits of EPA and DHA

But the data suggests otherwise, according to regulatory & scientific affairs VP Harry B. Rice, PhD: “Given that the last authoritative scientific review of EPA and DHA was over ten years ago… GOED respectfully disagrees that there is a ‘lack of well-established evidence for a role of n-3 … polyunsaturated fatty acids in chronic disease risk’.

In fact, a large and growing body of evidence supports the cardiovascular benefits of EPA and DHA, says Dr Rice, while at 113mg/day, US intakes of EPA and DHA are well below recommendations in the Dietary Guidelines for Americans (250mg/day).

In a formal comment on the FDA proposals - which among other things recommend removing vitamins A and C as mandatory listed micronutrients and replacing them with vitamin D and potassium - GOED urges the agency to at least include EPA and DHA on the list of ‘non-statutory nutrients’ firms will be allowed to list on the panel on a voluntary basis.

US intakes of EPA and DHA are well below recommendations in the Dietary Guidelines

As the FDA (click HERE) itself notes, says Dr Rice, “The 2010 Dietary Guidelines Advisory Committee concluded that moderate evidence shows that the consumption of two servings of seafood per week, which provides an average of 250 mg/day of EPA and DHA is associated with reduced cardiac mortality from coronary heart disease or sudden deaths, both in persons with and without cardiovascular disease.”

Indeed, the first sentence of the ‘Nutrients of Concern’ section of the guidelines says that intakes of seafood - a key source of EPA & DHA - are lower than recommended, and that as a result, intakes of some nutrients are ‘low enough to be of public health concern’, he points out.

“Specifically, the article cited as the source of evidence regarding EPA and DHA supplementation by the Nutrient Adequacy Subcommittee concluded that ‘National public health initiatives to increase omega-3 fatty acid consumption are needed; the working group believes that data are currently sufficient to indicate that intake of omega-3 fatty acids is suboptimal, and a national and international initiative should be launched to shift omega-3 fatty acid intake upward.”

While simply listing EPA and DHA on nutrition facts labels will not in itself boost intakes, he acknowledges, it will “go a long way to assist consumers in maintaining healthy dietary practices”.

Technological advances have made adding lc omega-3s to foods and beverages easier

The FDA recently frustrated many players in the omega-3 industry by publishing a final rule prohibiting certain nutrient content claims about EPA and DHA on food labels on the grounds that no reference levels have been established for these nutrients.  

However, there is still enthusiasm for adding long chain omega-3s to food and beverage products, with firms such as Cargill recently introducing a cost-effective ‘drop-in’ solution for food & beverage EPA/DHA fortification called IngreVita.

Meanwhile, Virun has developed patented technology enabling the inclusion of EPA+DHA (which are prone to oxidation, causing taste, odor and stability problems) in clean label shelf-stable foods and beverages at unprecedented levels.

According to GOED estimates, volumes of algal DHA used in infant formula rose in 2013, while volumes of EPA and DHA of marine origin used in other food products (primarily from fish oil, but also algal omega-3s) were fairly flat.

Think you need to pop pills to get a decent dose of omega-3? Think again

Click HERE to read all the comments in the docket on the FDA Nutrition Facts proposal. 

Related News

CRN, NPA submit comments on FDA's proposed changes to food, supplement labels

CRN, NPA submit comments on FDA's proposed changes to food, supplement labels

Does vitamin D belong on the Nutrition Facts panel?

Does vitamin D belong on the Nutrition Facts panel?

Study: omega-3 uptake higher in women; we must account for gender in research, GOED VP says

Study: omega-3 uptake higher in women; we must account for gender in research, GOED VP says

FDA's current and proposed Nutrition Facts updates, protein content, declared protein, folate, folic acid, added sugar

AHPA to FDA: Clarify protein labeling

Technology enables firms to add unprecedented levels of omega-3s into shelf-stable foods & beverages and keep their labels clean...

Think you need to pop pills to get a decent dose of omega-3? Think again, say Hormel and Virun

Cargill: 'We wanted something that was easy to use at a low cost per serving'

EPA, DHA for the masses? Cargill unveils cost-effective ‘drop-in’ solution for F&B omega-3 fortification

The rule to prohibit statements on the labels of food products and dietary supplements that claim the products are “high in” DHA or EPA, and synonyms such as “rich in” and “excellent source of"

FDA prohibition of omega-3 nutrient content claims ‘in no way reflects the well-substantiated benefits associated with EPA & DHA’, says GOED

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.